Moberg Pharma reports topline data in the North American phase 3 study and will regain rights to MOB-015 in EU December 10, 2024
DanCann Pharma A/S Recommends Experienced Politician and Senior Government Official to Join the Board of Directors November 25, 2024
DanCann Pharma A/S Publishes Q3-2024 Report: Steady Growth in Medicinal Cannabis Prescriptions Signals Promising Future for Patients November 22, 2024
DanCann Pharma A/S: The Danish Government Proposes Permanent Scheme for Prescription-Based Medicinal Cannabis for Danish Patients November 19, 2024
BioStock: Can we reverse diabetes? – Abarceo Pharma aims to develop the solution of the future November 16, 2024
